Su Shulan
Nanjing University of Chinese Medicine
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Su Shulan.
Journal of Ethnopharmacology | 2016
Yue Zhu; Xiuzhu Duan; Feiyu Huang; Xiaonan Cheng; Liu Zhang; Pei Liu; Su Shulan; Jinao Duan; Tina Ting-Xia Dong; Karl Wah Keung Tsim
ETHNOPHARMACOLOGICAL RELEVANCE Kai-Xin-San, an ancient formula composed of Ginseng Radix et Rhizoma, Polygalae Radix, Acori Tatarinowii Rhizoma and Poria, was frequently applied for major depression disorders for thousands of years. However, its molecular mechanism has not clearly been investigated. AIM OF THE STUDY We aimed to reveal the action mechanism of KXS on anti-depression on inducing neuronal differentiation on PC12 cells. MATERIALS AND METHODS A chemically standardized water extract of KXS was applied onto cultured PC12 cells in determining its effect on neurotransmitter regulation enzymes and neurite outgrowth. RESULTS Single KXS treatment showed obvious changes in the expression of neurofilament and neurotransmitter regulation enzymes, which in parallel to treatment of nerve growth factor (NGF). Although KXS by itself did not show significant inductive effect on neurite outgrowth of PC12 cells, KXS could potentiate the NGF induced neurite outgrowth. Among the three ratios, K-652 showed the most powerful effect and cAMP-dependent pathway might play the major role. CONCLUSIONS KXS might exert the anti-depressant-like action of be inducing neuronal differentiation, which supported the clinically usage of this decoction.
World Science and Technology | 2012
Duan Jin-ao; Su Shulan; Fan Xin-sheng; Qian Dawei; Tang Yu-ping; Shang Erxin; Guo Jianming; Liu Pei
Abstract This paper proposes three kinds of action patterns of traditional Chinese medicine (TCM) incompatibility based on the theories of Seven Ways of Compatibility and Drug Interaction. These are toxification and potential toxicity action pattern embodied in the characteristic of antagonism, efficiency reduction, and decrease in effect—patterns reflected by the characteristics of mutual inhibition/restraint and toxic-effect multiple action patterns embodying the complex characteristics of antagonism and mutual inhibition/restraint. In addition, we put forward eight possible mechanisms of TCM incompatibility. They are potential toxicity by promoting the release of toxic substances, potential toxicity by producing new toxic components, potential toxicity because of increased toxic components resulting from mutual transformation of chemical constituents, efficiency reduction through inhibiting the dissolving of active components, efficiency reduction through inactivating the active components, toxification that results from toxic metabolites generated in vivo based on drug interaction, adverse effects caused by affecting the physiological disposition of incompatibility combinations, and adverse effects caused by regulating and controlling the drug metabolic enzymes. Furthermore, the authors discussed the correlations between the different action patterns and mechanisms and relationships of the seven ways of compatibility. These opinions would provide references for understanding and researching the essences of TCM incompatibility.
药学学报 2018, Vol. 7, Pages 1148-1155 | 2018
王春雪; Wang Chun-xue; 王玲; Wang Ling; 钱大玮; Qian Dawei; 张黄琴; Zhang Huangqin; 黄文哲; Huang Wen-zhe; 王团结; Wang Tuanjie; 朱振华; Zhu Zhenhua; 宿树兰; Su Shulan; 郭盛; Guo Sheng; 段金廒; Duan Jinao
研究热毒宁注射液在大鼠体内的代谢产物。采用超高效液相色谱-线性离子阱-静电轨道阱串联质谱联用方法(UHPLC-LTQ-Orbitrap-MS)对大鼠尾静脉注射热毒宁后血浆、胆汁、尿液和粪便进行分析,利用质量亏损过滤(MDF)技术进行京尼平苷、京尼平苷酸、断氧化马钱子苷、绿原酸代谢产物分析鉴定,推测出大鼠体内京尼平苷氧化、脱水、去甲氧基、水解、开环、半胱氨酸结合和苷元葡萄糖醛酸结合等14个代谢产物;京尼平苷酸脱水、开环、双键还原和半胱氨酸结合等9个代谢产物;断氧化马钱子苷水解、去甲氧基、羟基化和乙基化等6个代谢产物;绿原酸脱羧、水解、甲基化、乙酰化、半胱氨酰甘氨酸结合和谷胱甘肽结合等12个代谢产物。为进一步探讨热毒宁注射液体内过程,阐明其功效物质基础提供依据。
Chinese Journal of Experimental Traditional Medical Formulae | 2008
Su Shulan; Duan Jinao; Yu Li
Archive | 2013
Duan Jin Ao; Qian Dawei; Shang Erxin; Tang Yuping; Su Shulan
Chinese Journal of Natural Medicines | 2010
Duan Jinao; Su Shulan; Qian Dawei; Tang Yu-ping; Zhou RongHan
Archive | 2014
Liu Pei; Duan Jinao; Qian Dawei; Su Shulan; Tang Yuping
China journal of Chinese materia medica | 2012
Liu Li; Duan Jinao; Hua Yongqing; Liu Pei; Shang Erxin; Tang Yuping; Su Shulan
China Journal of Traditional Chinese Medicine and Pharmacy | 2010
Tang Yu-ping; Hou PengFei; Duan Jinao; Liu Pei; Su Shulan
Archive | 2017
Su Shulan; Duan Jinao; Ma Xinfei; Guo Sheng; Qian Dawei